BR112017026422A2 - Uso de uma combinação de extratos de curcuma longa, punica granatum e zingiber officinale na prevenção e/ou tratamento de lesões de mucosa - Google Patents

Uso de uma combinação de extratos de curcuma longa, punica granatum e zingiber officinale na prevenção e/ou tratamento de lesões de mucosa

Info

Publication number
BR112017026422A2
BR112017026422A2 BR112017026422A BR112017026422A BR112017026422A2 BR 112017026422 A2 BR112017026422 A2 BR 112017026422A2 BR 112017026422 A BR112017026422 A BR 112017026422A BR 112017026422 A BR112017026422 A BR 112017026422A BR 112017026422 A2 BR112017026422 A2 BR 112017026422A2
Authority
BR
Brazil
Prior art keywords
prevention
treatment
combination
curcuma longa
punica granatum
Prior art date
Application number
BR112017026422A
Other languages
English (en)
Other versions
BR112017026422B1 (pt
Inventor
Raman Mehta
Original Assignee
Raman Mehta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raman Mehta filed Critical Raman Mehta
Publication of BR112017026422A2 publication Critical patent/BR112017026422A2/pt
Publication of BR112017026422B1 publication Critical patent/BR112017026422B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112017026422-6A 2015-06-10 2016-06-10 Uso de uma combinação de extratos de curcuma longa, punica granatum e zingiber officinale na prevenção e/ou tratamento de lesões de mucosa BR112017026422B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15171355.9A EP3103465A1 (en) 2015-06-10 2015-06-10 Formulations for the treatment of mucosal lesions
EP15171355.9 2015-06-10
PCT/IB2016/000791 WO2016198942A1 (en) 2015-06-10 2016-06-10 Formulations for the treatment of mucosal lesions

Publications (2)

Publication Number Publication Date
BR112017026422A2 true BR112017026422A2 (pt) 2018-08-21
BR112017026422B1 BR112017026422B1 (pt) 2021-10-05

Family

ID=53385534

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017026422-6A BR112017026422B1 (pt) 2015-06-10 2016-06-10 Uso de uma combinação de extratos de curcuma longa, punica granatum e zingiber officinale na prevenção e/ou tratamento de lesões de mucosa

Country Status (14)

Country Link
US (1) US10786540B2 (pt)
EP (2) EP3103465A1 (pt)
JP (1) JP6830482B2 (pt)
KR (1) KR20180030482A (pt)
CN (1) CN108012530B (pt)
AU (1) AU2016276144B2 (pt)
BR (1) BR112017026422B1 (pt)
ES (1) ES2728557T3 (pt)
HU (1) HUE045225T2 (pt)
MX (1) MX2017016029A (pt)
PL (1) PL3307292T3 (pt)
PT (1) PT3307292T (pt)
TR (1) TR201908166T4 (pt)
WO (1) WO2016198942A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023037299A1 (en) * 2021-09-09 2023-03-16 Integria Healthcare (Australia) Pty Limited Anti-inflammatory compositions comprising ginger and turmeric

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596313B2 (en) 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
US7166435B2 (en) * 2001-08-06 2007-01-23 The Quigley Corporation Compositions and methods for reducing the transmissivity of illnesses
CA2495447A1 (en) * 2002-08-06 2004-02-12 The Quigley Corporation Anti-microbial compositions and methods of using same
US7175987B2 (en) * 2002-08-06 2007-02-13 The Quigley Corporation Compositions and methods for treatment of herpes
US20080031979A1 (en) * 2006-08-04 2008-02-07 Claude Saliou Use of extracts for the treatment of viral disorders
US20090175971A1 (en) 2008-01-08 2009-07-09 Mark Dreher Method of using composition comprising pomegranate extracts against the common cold
DE202009002126U1 (de) * 2009-02-13 2009-04-16 Orthomol Pharmazeutische Vertriebs Gmbh Spurenelement enthaltende Zusammensetzung
KR101077920B1 (ko) 2009-07-08 2011-10-31 한국생명공학연구원 울금 추출물을 포함하는 인플루엔자 바이러스 감염의 예방 및 치료용 조성물 및 뉴라미니데이즈 활성의 억제용 조성물
CN102665674A (zh) * 2009-12-04 2012-09-12 高露洁-棕榄公司 含有天然提取物组合的口腔组合物及相关方法
IT1402018B1 (it) 2010-10-11 2013-08-28 Indena Spa Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
JP2013001666A (ja) * 2011-06-14 2013-01-07 Yasuharu Omura 栄養剤組成物
CN102670588B (zh) 2012-05-04 2013-11-20 中国科学院上海生命科学研究院湖州营养与健康产业创新中心 鞣花酸用于制备抗病毒药物的应用
CN103638502B (zh) * 2013-12-12 2015-07-01 苏振华 一种治疗白塞病的药物及其制备方法
CN103690709B (zh) * 2013-12-14 2016-03-09 青岛市中心医院 一种治疗肠白塞病的中药
CN104524508A (zh) 2014-12-24 2015-04-22 赵红 一种治疗消化性溃疡的中药及其制备方法
EP3103464A1 (en) * 2015-06-10 2016-12-14 Raman Mehta Formulations for the treatment of disorders of the mouth, throat and respiratory tract

Also Published As

Publication number Publication date
KR20180030482A (ko) 2018-03-23
US10786540B2 (en) 2020-09-29
ES2728557T3 (es) 2019-10-25
EP3307292B1 (en) 2019-03-13
MX2017016029A (es) 2018-04-13
EP3307292A1 (en) 2018-04-18
HUE045225T2 (hu) 2019-12-30
BR112017026422B1 (pt) 2021-10-05
CN108012530A (zh) 2018-05-08
PT3307292T (pt) 2019-05-31
AU2016276144B2 (en) 2022-01-13
AU2016276144A1 (en) 2017-12-21
WO2016198942A1 (en) 2016-12-15
PL3307292T3 (pl) 2020-01-31
EP3103465A1 (en) 2016-12-14
JP6830482B2 (ja) 2021-02-17
US20180104301A1 (en) 2018-04-19
CN108012530B (zh) 2021-07-02
JP2018521124A (ja) 2018-08-02
TR201908166T4 (tr) 2019-06-21

Similar Documents

Publication Publication Date Title
IL282629A (en) Formulation based on medicinal plant, part or extract of the it, use of the formulation and product comprising that formulation
BR112018001187A2 (pt) materiais e métodos para melhorar as respostas imunes e funções de barreira de pele e/ou mucosa
PH12016502500A1 (en) Influenza virus vaccines and uses thereof
CY1119633T1 (el) Νεες φαρμακοτεχνικες μορφες αποτελουμενες απο φυτικα εκχυλισματα
TR201908938T4 (tr) Ağız, boğaz ve solunum yolu rahatsızlıklarının tedavisi için formülasyonlar.
IL247314A0 (en) Preparations containing extracts of Curcuma longa and Echinacea angustifolia used to reduce peripheral inflammation and pain
MA44657A (fr) Souches de pseudomonas et consortiums correspondantes destinées à être utilisées dans la protection contre des maladies de plante
PT3651804T (pt) Solubilizado com curcumina e boswellia e xanthohumol
EP3541185A4 (en) USE OF 2-HYDROXYBENZYLAMINE IN THE TREATMENT AND PREVENTION OF PULMONARY HYPERTENSION
BR112017026422A2 (pt) Uso de uma combinação de extratos de curcuma longa, punica granatum e zingiber officinale na prevenção e/ou tratamento de lesões de mucosa
EP3464534A4 (en) AQUEOUS CLEANING COMPOSITIONS AND USE THEREOF
PT3423042T (pt) Formulação farmacêutica liofilizada e sua utilização
HK1222805A1 (zh) 鋸棕櫚提取物與生姜和狹葉松果菊的脂溶性提取物的組合、其用途和含有它們的製劑
SG11202003668YA (en) Betulin-containing birch bark extracts and their formulation
EP3714886A4 (en) PHARMACEUTICAL COMPOSITION FOR PROTECTING OR AMENDING RADIOACTIVE DAMAGE AND FOR THE PREVENTION OR TREATMENT OF LUNG FIBROSIS
EP3512770A4 (en) BALLAST WATER TREATMENT AND NEUTRALIZATION
HUE055457T2 (hu) Geraniolt és száraz gyömbért tartalmazó készítmények az irritábilis bél szindróma kezelésében való felhasználásra
EP3247333A4 (en) Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration
SG10201902573TA (en) Acupressure sleeve having far infrared and negativeion double effect energy
IN2013DE03120A (pt)
MX2019007078A (es) Procedimiento para la preparacion de composiciones en polvo.
UA88472U (ru) Лекарственное средство, оказывающее желчегонное, гепатопротекторное, спазмолитическое и противовоспалительное действие в отношении желчных путей в организме человека
GB201604687D0 (en) Means and Methods for the Prevention of Joint Destruction
CL2015002209A1 (es) Composición antiséptica oral para tratamiento de mucositis oral.
AU2016902087A0 (en) Aqueous cleaning compositions and the use thereof

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/06/2016, OBSERVADAS AS CONDICOES LEGAIS.